Search results
Results from the WOW.Com Content Network
Lingzhi, Ganoderma sichuanense, also known as reishi or Ganoderma lingzhi [3] is a polypore fungus ("bracket fungus") native to East Asia belonging to the genus Ganoderma.. Its reddish brown, varnished, kidney-shaped cap with bands and peripherally inserted stem give it a distinct fan-like appearance.
After treatment with white button mushroom extract in mice and patients with prostate cancer, scientists discovered a decline in the amount of immune-suppressing cells in tumors.
Ganoderma lucidum, commonly known as the reishi, varnished conk, or ling chih, [2] is a red-colored species of Ganoderma with a limited distribution in Europe and parts of China, where it grows on decaying hardwood trees. [3]
Ganoderma sinense - Also known as black reishi or zizhi. Ganoderma tsugae - A polypore which grows on conifers , especially hemlock , giving it its common name, hemlock varnish shelf . Similar in appearance to Ganoderma lucidum and a close relative, which typically grows on hardwoods .
Ganoderma oregonense (also known as the west-coast reishi, western varnished conk, lacquer fungus, and/or American ling-chi) is a species of bracket fungus that causes root and butt white rot in conifers in northwestern coastal North America, [2] [3] including California, Oregon, Washington, British Columbia, Yukon, and Alaska. [4]
Like G. lucidum, G. tsugae is purported to have medicinal properties including use for dressing a skin wound. [4] Though phylogenetic analysis has begun to better differentiate between many closely related species of Ganoderma; [5] there is still disagreement as to which have the most medicinal properties.
A drawing on the lower side of the sporocarp of G. applanatum. A peculiarity of this fungus lies in its use as a drawing medium for artists. [13] When the fresh white pore surface is rubbed or scratched with a sharp implement, dark brown tissue under the pores is revealed, resulting in visible lines and shading that become permanent once the fungus is dried.
For men over 64 with prostate cancer limited to the pelvis, using fewer, larger doses of radiation (hypofractionation) results in similar overall survival rates. [28] The risk of dying from prostate cancer or having acute bladder side effects may be similar to that of longer radiation treatment. [28]